37
https://pubmed.ncbi.nlm.nih.gov/38112106
Azvudine and nirmatrelvir-ritonavir were found to improve the prognosis of hospitalized adults with moderate-to-severe COVID-19.
https://pubmed.ncbi.nlm.nih.gov/38112106
Azvudine and nirmatrelvir-ritonavir were found to improve the prognosis of hospitalized adults with moderate-to-severe COVID-19.